FDA advisors unanimously vote to approve Moderna's mRNA after agency drama
In February, a Trump official refused to review the vaccine. https://arstechnica.com/health/2026/06/fda-advisors-unanimously-vote-to-approve-modernas-mrna-after-agency-drama/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social
Comments (3)
@arstechnica As Claire Marie Porter, reporter with The Cancer Letter said: "Right now drug companies are mad [at Prasad], rare disease patients and advocates are mad, and now Congress people are mad, which is a lot of mad people,” Claire said. “And I think when you’ve united pharma, Congress, and patients, that’s almost impressive.”
https://cancerletter.com/podcastc/20260315-vinay-prasad/
@arstechnica
Under the current administration a scientific review process might consist of, and solely of, a significant purchase of the Predator in Chief’s meme coin
@arstechnica "Independent" advisors...
That's a hoot!